CYduct Diagnostics Granted Patent for Precision Medicine-Based Breast Cancer Risk Assessment Test
Breakthrough Innovation Aims to Enable the Earliest Possible Detection of Breast Cancer CYduct Diagnostics (OTCMKTS:CYDX) WESTPORT, CT, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- CYduct Diagnostics, Inc. (OTCPK: CYDX), a leader in …